Top Markets
#1 Cortex Cortex +173.96%
#2 Helium Helium +53.83%
#3 GEKKO GEKKO +51.79%
#4 Pons Pons +23.61%
#5 ADO Protocol ADO Protocol +18.10%
#6 o1.exchange o1.exchange +16.40%
#7 Status Status +11.80%
#8 Siren Siren +11.47%
#9 Ontology Gas Ontology Gas +10.14%
#10 Audiera Audiera +9.54%
Coin of the day
Cortex Cortex
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classement en actions #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Prix de l'action
$59.98
Dernière synchronisation: 2024-12-13
Capitalisation boursière
$1.22B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Longboard Pharmaceuticals, Inc. (LBPH)

Catégorie

Healthcare
Ratio P/S pour Longboard Pharmaceuticals, Inc. (LBPH)
Ratio P/S au August 2026 TTM : 0.00
Selon les derniers rapports financiers et le cours de l'action de Longboard Pharmaceuticals, Inc., le ratio cours/ventes actuel (TTM) est 0.00. À la fin de 2022, le ratio P/S était de 0.00.
Historique du ratio P/S pour Longboard Pharmaceuticals, Inc. de 2020 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH